Cubist Systematic Strategies’s Filana Therapeutics FLNA Stock Holding History

Cubist Systematic Strategies’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$437K	Sell	150,088 -159,613	-52%	-$367K	﹤0.01%	2338
2025 Q2	$561K	Buy	+309,701	New	+$551K	﹤0.01%	2212
2025 Q1	–	Sell	-533	Closed	-$1.26K	–	3435
2024 Q4	$1.26K	Buy	+533	New	+$9.36K	﹤0.01%	2898
2022 Q4	–	Sell	-18,036	Closed	-$754K	–	4551
2022 Q3	$754K	Buy	+18,036	New	+$487K	﹤0.01%	2855
2022 Q1	–	Sell	-918	Closed	-$40K	–	3744
2021 Q4	$40K	Sell	918 -5,651	-86%	-$296K	﹤0.01%	3331
2021 Q3	$408K	Sell	6,569 -3,931	-37%	-$328K	0.01%	2165
2021 Q2	$897K	Buy	+10,500	New	+$562K	0.01%	1661
2020 Q4	–	Sell	-22,200	Closed	-$256K	–	2693
2020 Q3	$256K	Buy	+22,200	New	+$100K	﹤0.01%	2040
2014 Q3	–	Sell	-1,454	Closed	-$59K	–	1859
2014 Q2	$59K	Buy	+1,454	New	+$53.8K	﹤0.01%	1398

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cubist Systematic Strategies's FLNA Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Filana Therapeutics (FLNA) stake by 52% in Q3 2025, selling an estimated $367K and leaving 150,088 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

Cubist Systematic Strategies first reported a position in FLNA in Q2 2014 and has held it in 9 quarters since. The position peaked at $897K in Q2 2021. 103 funds tracked by Wall St. Rank hold FLNA as of Q3 2025.

Cubist Systematic Strategies held 150,088 shares of Filana Therapeutics worth $437K as of Q3 2025.
Cubist Systematic Strategies sold 159,613 Filana Therapeutics shares in Q3 2025, an estimated $367K.
Filana Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2338 holding.
Cubist Systematic Strategies first reported a position in Filana Therapeutics in Q2 2014 and has held it in 9 quarters since.
Cubist Systematic Strategies's Filana Therapeutics position peaked at $897K in Q2 2021.
103 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.